Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jenhjackson
    Junior Member
    • Aug 2010
    • 2

    #1

    Cheers from Jen Jackson

    Hi everyone -

    I've been a stalker for a while and now finally a member ...

    In my career, I've been lucky enough to have been working with genomic information and tool packages in both Industry and Academia for [gasp] 16 years.

    Recently, I've started working with the Penn State Galaxy project. I've also been working on and off with UCSC's Genome Browser team for close to 6 years. Before that, I was with Incyte Pharmaceuticals/Genomics/Corporation for 10 years, where we changed our name a lot and I was fortunate enough to be there at the beginning and to turn off the light on my way out of the Palo Alto site.

    I am a hybrid scientist, techie, project/staff manager, and teacher. I'll tell you that I don't code, but that would be a lie, I just don't do it for anyone else. I also do not do active research anymore, which would not be a lie, but I still have pretty strong opinions about what constitutes valid research methods. But, I am great at helping others to do both, which I also think is not a lie, but perhaps you'll all let me know.

    Hopefully, I'll be able to learn a lot and help out a bit where I can.

    Nice to be here!

    jen
    Jennifer Hillman Jackson
    http://usegalaxy.org

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...